This study compares baseline (J0) and 24-hour (J1) diffusion magnetic resonance imaging (MRI) for predicting three-month functional outcomes after acute ischemic stroke (AIS). Seventy-four AIS patients with paired apparent diffusion coefficient (ADC) scans and clinical data were analyzed. Three-dimensional ResNet-50 embeddings were fused with structured clinical variables, reduced via principal component analysis (<=12 components), and classified using linear support vector machines with eight-fold stratified group cross-validation. J1 multimodal models achieved the highest predictive performance (AUC = 0.923 +/- 0.085), outperforming J0-based configurations (AUC <= 0.86). Incorporating lesion-volume features further improved model stability and interpretability. These findings demonstrate that early post-treatment diffusion MRI provides superior prognostic value to pre-treatment imaging and that combining MRI, clinical, and lesion-volume features produces a robust and interpretable framework for predicting three-month functional outcomes in AIS patients.

The focus in machine learning has branched beyond training classifiers on a single task to investigating how previously acquired knowledge in a source domain can be leveraged to facilitate learning in a related target domain, known as inductive transfer learning. Three active lines of research have independently explored transfer learning using neural networks. In weight transfer, a model trained on the source domain is used as an initialization point for a network to be trained on the target domain. In deep metric learning, the source domain is used to construct an embedding that captures class structure in both the source and target domains. In few-shot learning, the focus is on generalizing well in the target domain based on a limited number of labeled examples. We compare state-of-the-art methods from these three paradigms and also explore hybrid adapted-embedding methods that use limited target-domain data to fine tune embeddings constructed from source-domain data. We conduct a systematic comparison of methods in a variety of domains, varying the number of labeled instances available in the target domain (k), as well as the number of target-domain classes. We reach three principal conclusions: (1) Deep embeddings are far superior, compared to weight transfer, as a starting point for inter-domain transfer or model re-use (2) Our hybrid methods robustly outperform every few-shot learning and every deep metric learning method previously proposed, with a mean error reduction of 34% over state-of-the-art.

The focus in machine learning has branched beyond training classifiers on a single task to investigating how previously acquired knowledge in a source domain can be leveraged to facilitate learning in a related target domain, known as inductive transfer learning. Three active lines of research have independently explored transfer learning using neural networks. In weight transfer, a model trained on the source domain is used as an initialization point for a network to be trained on the target domain. In deep metric learning, the source domain is used to construct an embedding that captures class structure in both the source and target domains. In few-shot learning, the focus is on generalizing well in the target domain based on a limited number of labeled examples.

I went back and read the main paper one more time. This hybrid approach robustly outperforms every few-shot learning and every deep metric learning method previously proposed on k-ITL. " 2) L144-147: "In contrast, weight adaptation determines model parameters using both source and target domain data. We explore a straightforward hybrid, adapted embeddings, which unifies embedding methods and weight adaptation by using the target-domain support set for model-parameter adaptation" In plain English, this is just saying: "We use the test *and* train set to train embeddings in contrast to the standard practice of only using the train set" and it empirically worked slightly better. It's a no brainer that the performance increases as you also train on more (k) test data.

The focus in machine learning has branched beyond training classifiers on a single task to investigating how previously acquired knowledge in a source domain can be leveraged to facilitate learning in a related target domain, known as inductive transfer learning. Three active lines of research have independently explored transfer learning using neural networks. In weight transfer, a model trained on the source domain is used as an initialization point for a network to be trained on the target domain. In deep metric learning, the source domain is used to construct an embedding that captures class structure in both the source and target domains. In few-shot learning, the focus is on generalizing well in the target domain based on a limited number of labeled examples.

Clinical trials are essential for drug development but often suffer from expensive, inaccurate and insufficient patient recruitment. The core problem of patient-trial matching is to find qualified patients for a trial, where patient information is stored in electronic health records (EHR) while trial eligibility criteria (EC) are described in text documents available on the web. How to represent longitudinal patient EHR? How to extract complex logical rules from EC? Most existing works rely on manual rule-based extraction, which is time consuming and inflexible for complex inference. To address these challenges, we proposed DeepEnroll, a cross-modal inference learning model to jointly encode enrollment criteria (text) and patients records (tabular data) into a shared latent space for matching inference. DeepEnroll applies a pre-trained Bidirectional Encoder Representations from Transformers(BERT) model to encode clinical trial information into sentence embedding. And uses a hierarchical embedding model to represent patient longitudinal EHR. In addition, DeepEnroll is augmented by a numerical information embedding and entailment module to reason over numerical information in both EC and EHR. These encoders are trained jointly to optimize patient-trial matching score. We evaluated DeepEnroll on the trial-patient matching task with demonstrated on real world datasets. DeepEnroll outperformed the best baseline by up to 12.4% in average F1.